Improving understanding of nicotine levels in electronic cigarettes
Using Novel Labeling to Improve Public Understanding of Nicotine in Electronic Nicotine Delivery Systems (ENDS): Nicotine Concentration and Nicotine Flux
This study is working on new, clearer labels for e-cigarettes to help smokers make better choices and to keep young people from using high-nicotine products, making it easier for everyone to understand how much nicotine is in these devices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10938155 on NIH RePORTER |
What this research studies
This research aims to enhance public understanding of nicotine concentrations in electronic nicotine delivery systems (ENDS) by developing new labeling methods. The study will focus on creating two types of labels: one that replaces existing FDA-required nicotine concentration labels and another that provides information on nicotine emissions from popular devices like JUUL and Vuse. By refining these labels, the research seeks to help smokers make informed choices when switching to ENDS and to deter youth from using high-nicotine products. The approach includes testing the effectiveness of these labels in real-world settings to ensure they are easily understood by both adults and youth.
Who could benefit from this research
Good fit: Ideal candidates for this research include adult smokers looking to switch to ENDS and youth who may be at risk of using these products.
Not a fit: Patients who do not use nicotine products or have no interest in switching to ENDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed choices regarding nicotine use, potentially reducing nicotine dependence and improving public health outcomes.
How similar studies have performed: Previous pilot studies have shown success in improving understanding of nicotine labeling, indicating that this approach has potential for further development.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Morean, Meghan E — Yale University
- Study coordinator: Morean, Meghan E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.